Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are current treatments for advanced non-small cell lung cancer (NSCLC) harboring activating EGFR gene mutations. Histological or cytological samples are the standard tumor materials for EGFR mutation analysis. However, the acces...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transl Lung Cancer Res
Päätekijät: Bordi, Paola, Del Re, Marzia, Danesi, Romano, Tiseo, Marcello
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2015
Aiheet:
Review Article on Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4630520/
https://ncbi.nlm.nih.gov/pubmed/26629427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2015.08.09
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia